Evidence map›Paper›PMID 28211872›Full record

ArticleCell death and differentiation2017

Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.

Beatrice Tassone, Stefania Saoncella, Francesco Neri, Ugo Ala, Davide Brusa, Mark A Magnuson, Paolo Provero, Salvatore Oliviero, Chiara Riganti, Enzo Calautti

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. RICTOR/mTORC2 downregulation in BRAFMolecular cancer · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Loss ofFrontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Beatrice TassoneDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Stefania SaoncellaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Francesco NeriDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Ugo AlaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Davide BrusaHuman Genetics Foundation (HuGeF), Turin, Italy.
Mark A MagnusonDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Paolo ProveroDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-8664-8630
Salvatore OlivieroHuman Genetics Foundation (HuGeF), Turin, Italy.ORCID 0000-0002-3405-765X
Chiara RigantiDepartment of Oncology, University of Turin, Turin, Italy.ORCID 0000-0001-9787-4836
Enzo CalauttiDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
University of Turin · ITItalian institute for Genomic Medicine · ITVanderbilt University · US

Funding

Telethon TCP06001
6 · The paper itself

Abstract

How metabolic pathways required for epidermal tissue growth and remodeling influence the ability of keratinocytes to survive stressful conditions is still largely unknown. The mechanistic target of rapamycin complex 2 (mTORC2) regulates growth and metabolism of several tissues, but its functions in epidermal cells are poorly defined. Rictor is an adaptor protein essential for mTORC2 activity. To explore the roles of mTORC2 in the epidermis, we have conditionally deleted rictor in mice via K14-Cre-mediated homologous recombination and found that its deficiency causes moderate tissue hypoplasia, reduced keratinocyte proliferation and attenuated hyperplastic response to TPA. Noteworthy, rictor-deficient keratinocytes displayed increased lifespan, protection from senescence, and enhanced tolerance to cellular stressors such as growth factors deprivation, epirubicin and X-ray in vitro and radioresistance in vivo. Rictor-deficient keratinocytes exhibited changes in global gene expression profiles consistent with metabolic alterations and enhanced stress tolerance, a shift in cell catabolic processes from glycids and lipids to glutamine consumption and increased production of mitochondrial reactive oxygen species (ROS). Mechanistically, the resiliency of rictor-deficient epidermal cells relies on these ROS increases, indicating stress resistance via mitohormesis. Thus, our findings reveal a new link between metabolic changes and stress adaptation of keratinocytes centered on mTORC2 activity, with potential implications in skin aging and therapeutic resistance of epithelial tumors.

Indexed as

AcetylcysteineAnimalsApoptosisCell ProliferationCells, CulturedCellular SenescenceEpirubicinGlutamic AcidHyperplasiaKeratin-14KeratinocytesMiceMice, Inbred C57BLMice, KnockoutMitochondriaRadiation Tolerance12-O-tetradecanoylphorbol-1,3-acetateAcetylcysteineEpirubicinGlutamic AcidKeratin-14Rapamycin-Insensitive Companion of mTOR ProteinReactive Oxygen Speciesrictor protein, mouseTetradecanoylphorbol Acetate

Identifiers

PMID28211872
PMCPMC5384034
OpenAlexW2589091658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.